Cardiac Resynchronization Therapy Market Size, Share, Industry Analysis and Global Forecast to 2030

The global Cardiac Resynchronization Therapy (CRT) market size was USD 4.20 Billion in 2022 and is expected to register a steady revenue CAGR of 4.8% during the forecast period, according to latest analysis by Emergen Research.

Read More: https://www.emergenresearch.co....m/industry-report/ca

Technological advancements, rising sedentary lifestyles, and increasing geriatric population are major factors driving market revenue growth.Therapies using an implantable device have become a crucial therapy option owing to rise in number of patients suffering from heart failure and difficulties in managing severe heart failure syndromes in clinical practice. These treatments can be divided into two main groups depending on the kind of heart failure. As a standard of care, Cardiac Resynchronization Therapy (CRT) is used to treat patients with ventricular dyssynchrony, an abnormality of heart rhythm. CRT uses an implantable biventricular pacemaker to synchronize left and right ventricles of heart and increase cardiac output. The CRT system is made up of an implantable pulse generator and insulated lead wires that are used to transmit electrical charges to the heart, aiding in restoration of heartbeat's regular timing pattern.